(F) Ford Motor - Overview
Stock: Trucks, SUVs, Vans, Cars, EVs
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 7.14% |
| Yield on Cost 5y | 8.55% |
| Yield CAGR 5y | 65.49% |
| Payout Consistency | 75.1% |
| Payout Ratio | 62.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 32.0% |
| Relative Tail Risk | -8.35% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.50 |
| Alpha | 34.09 |
| Character TTM | |
|---|---|
| Beta | 0.857 |
| Beta Downside | 0.685 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.51% |
| CAGR/Max DD | 0.25 |
Description: F Ford Motor January 28, 2026
Ford Motor Company (NYSE:F) designs, manufactures, and services a portfolio that includes Ford trucks, SUVs, commercial vans, passenger cars, and Lincoln luxury models. Its operations are organized into four segments: Ford Blue (traditional ICE and hybrid vehicles), Ford Model e (electric-vehicle development), Ford Pro (commercial-fleet solutions), and Ford Credit (automotive financing and leasing).
In the most recent quarter (Q3 2024), Ford reported revenue of **$30.5 billion**, a **7% year-over-year increase**, driven primarily by a **15% rise in EV and hybrid sales** and a **3% lift in commercial-fleet deliveries**. Operating profit improved to **$2.1 billion**, reflecting a **14% operating margin**, up from 11% a year earlier, while free cash flow reached **$1.8 billion** after a modest rise in capital expenditures for battery-pack production.
Key macro drivers affecting Ford’s outlook include: (1) **U.S. consumer auto loan rates**, which have risen to **7.2%** (average 30-month new-car loan) and could pressure demand for higher-priced EVs; (2) **Federal EV tax-credit extensions** that remain uncertain beyond 2024, influencing buyer incentives; and (3) **Global semiconductor supply** that is stabilizing after a two-year shortage, allowing the company to meet its projected **2025 EV volume target of 850,000 units**.
For a deeper, data-driven assessment of how these variables interact with Ford’s valuation, you might explore the detailed analytics available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 4.71b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 1.72 > 1.0 |
| NWC/Revenue: 7.42% < 20% (prev 8.79%; Δ -1.37% < -1%) |
| CFO/TA 0.07 > 3% & CFO 20.43b > Net Income 4.71b |
| Net Debt (137.49b) to EBITDA (12.30b): 11.18 < 3 |
| Current Ratio: 1.12 > 1.5 & < 3 |
| Outstanding Shares: last quarter (4.05b) vs 12m ago 0.75% < -2% |
| Gross Margin: 7.53% > 18% (prev 0.08%; Δ 745.2% > 0.5%) |
| Asset Turnover: 64.48% > 50% (prev 63.66%; Δ 0.82% > 0%) |
| Interest Coverage Ratio: 5.36 > 6 (EBITDA TTM 12.30b / Interest Expense TTM 1.22b) |
Altman Z'' 0.93
| A: 0.05 (Total Current Assets 130.72b - Total Current Liabilities 116.65b) / Total Assets 300.99b |
| B: 0.11 (Retained Earnings 34.19b / Total Assets 300.99b) |
| C: 0.02 (EBIT TTM 6.51b / Avg Total Assets 294.02b) |
| D: 0.10 (Book Value of Equity 26.36b / Total Liabilities 253.57b) |
| Altman-Z'' Score: 0.93 = BB |
Beneish M -2.82
| DSRI: 0.99 (Receivables 67.41b/65.81b, Revenue 189.59b/182.74b) |
| GMI: 1.02 (GM 7.53% / 7.68%) |
| AQI: 1.39 (AQ_t 0.48 / AQ_t-1 0.34) |
| SGI: 1.04 (Revenue 189.59b / 182.74b) |
| TATA: -0.05 (NI 4.71b - CFO 20.43b) / TA 300.99b) |
| Beneish M-Score: -2.82 (Cap -4..+1) = A |
What is the price of F shares?
Over the past week, the price has changed by -0.58%, over one month by +0.00%, over three months by +6.40% and over the past year by +60.07%.
Is F a buy, sell or hold?
- StrongBuy: 3
- Buy: 2
- Hold: 17
- Sell: 1
- StrongSell: 3
What are the forecasts/targets for the F price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 13.8 | -0.3% |
| Analysts Target Price | 13.8 | -0.3% |
| ValueRay Target Price | 16.7 | 21% |
F Fundamental Data Overview February 07, 2026
P/E Forward = 9.7371
P/S = 0.2883
P/B = 1.1619
P/EG = 10.8138
Revenue TTM = 189.59b USD
EBIT TTM = 6.51b USD
EBITDA TTM = 12.30b USD
Long Term Debt = 104.31b USD (from longTermDebt, last quarter)
Short Term Debt = 58.19b USD (from shortTermDebt, last quarter)
Debt = 164.28b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 137.49b USD (from netDebt column, last quarter)
Enterprise Value = 192.16b USD (54.67b + Debt 164.28b - CCE 26.79b)
Interest Coverage Ratio = 5.36 (Ebit TTM 6.51b / Interest Expense TTM 1.22b)
EV/FCF = 16.15x (Enterprise Value 192.16b / FCF TTM 11.90b)
FCF Yield = 6.19% (FCF TTM 11.90b / Enterprise Value 192.16b)
FCF Margin = 6.28% (FCF TTM 11.90b / Revenue TTM 189.59b)
Net Margin = 2.48% (Net Income TTM 4.71b / Revenue TTM 189.59b)
Gross Margin = 7.53% ((Revenue TTM 189.59b - Cost of Revenue TTM 175.31b) / Revenue TTM)
Gross Margin QoQ = 8.51% (prev 6.41%)
Tobins Q-Ratio = 0.64 (Enterprise Value 192.16b / Total Assets 300.99b)
Interest Expense / Debt = 0.20% (Interest Expense 321.0m / Debt 164.28b)
Taxrate = 18.51% (1.34b / 7.23b)
NOPAT = 5.30b (EBIT 6.51b * (1 - 18.51%))
Current Ratio = 1.12 (Total Current Assets 130.72b / Total Current Liabilities 116.65b)
Debt / Equity = 3.47 (Debt 164.28b / totalStockholderEquity, last quarter 47.39b)
Debt / EBITDA = 11.18 (Net Debt 137.49b / EBITDA 12.30b)
Debt / FCF = 11.56 (Net Debt 137.49b / FCF TTM 11.90b)
Total Stockholder Equity = 45.48b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.60% (Net Income 4.71b / Total Assets 300.99b)
RoE = 10.35% (Net Income TTM 4.71b / Total Stockholder Equity 45.48b)
RoCE = 4.35% (EBIT 6.51b / Capital Employed (Equity 45.48b + L.T.Debt 104.31b))
RoIC = 2.60% (NOPAT 5.30b / Invested Capital 203.84b)
WACC = 2.38% (E(54.67b)/V(218.95b) * Re(9.07%) + D(164.28b)/V(218.95b) * Rd(0.20%) * (1-Tc(0.19)))
Discount Rate = 9.07% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.20%
[DCF Debug] Terminal Value 86.97% ; FCFF base≈9.70b ; Y1≈10.36b ; Y5≈12.53b
Fair Price DCF = 59.64 (EV 370.90b - Net Debt 137.49b = Equity 233.41b / Shares 3.91b; r=5.90% [WACC]; 5y FCF grow 7.64% → 2.90% )
EPS Correlation: -17.75 | EPS CAGR: 15.75% | SUE: 0.88 | # QB: 1
Revenue Correlation: 80.47 | Revenue CAGR: 8.14% | SUE: 2.38 | # QB: 6
EPS next Quarter (2026-03-31): EPS=0.25 | Chg30d=+0.003 | Revisions Net=+0 | Analysts=7
EPS next Year (2026-12-31): EPS=1.55 | Chg30d=+0.067 | Revisions Net=+10 | Growth EPS=+36.7% | Growth Revenue=+1.0%